Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Pignon

Showing results (101-110 of 125) with videos related to

Pageof 13
Sort By:
Anticancer Research|January 1, 1994
Effect of thoracic radiotherapy on mortality in limited small cell lung cancer. A meta-analysis of 13 randomized trials among 2,140 patientsR Arriagada, J P Pignon, D C Ihde, et al.
The New England Journal of Medicine|December 3, 1992
A meta-analysis of thoracic radiotherapy for small-cell lung cancerJ P Pignon, R Arriagada, D C Ihde, et al.
The New England Journal of Medicine|August 12, 1999
Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative GroupA Aupérin, R Arriagada, J P Pignon, et al.
The European Respiratory Journal|June 11, 2011
Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3I Borget, J Cadranel, J-P Pignon, et al.
Lung Cancer (Amsterdam, Netherlands)|January 21, 2014
Does KRAS mutational status predict chemoresistance in advanced non-small cell lung cancer (NSCLC)?M Macerelli, C Caramella, L Faivre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 14, 2017
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trialsD Arnold, B Lueza, J-Y Douillard, et al.
British Journal of Cancer|March 25, 2000
Extensive molecular screening for hereditary non-polyposis colorectal cancerB Dieumegard, S Grandjouan, J C Sabourin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2011
Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trialsT Reiman, R Lai, A S Veillard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2015
Phase I trial of everolimus in combination with thoracic radiotherapy in non-small-cell lung cancerE Deutsch, C Le Péchoux, L Faivre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2002
A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinomaM Ducreux, P Rougier, J-P Pignon, et al.
Pageof 13

Showing results (101-110 of 125) with videos related to

Sort By:
Pageof 13
Anticancer Research|January 1, 1994
Effect of thoracic radiotherapy on mortality in limited small cell lung cancer. A meta-analysis of 13 randomized trials among 2,140 patientsR Arriagada, J P Pignon, D C Ihde, et al.
The New England Journal of Medicine|December 3, 1992
A meta-analysis of thoracic radiotherapy for small-cell lung cancerJ P Pignon, R Arriagada, D C Ihde, et al.
The New England Journal of Medicine|August 12, 1999
Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative GroupA Aupérin, R Arriagada, J P Pignon, et al.
The European Respiratory Journal|June 11, 2011
Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3I Borget, J Cadranel, J-P Pignon, et al.
Lung Cancer (Amsterdam, Netherlands)|January 21, 2014
Does KRAS mutational status predict chemoresistance in advanced non-small cell lung cancer (NSCLC)?M Macerelli, C Caramella, L Faivre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 14, 2017
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trialsD Arnold, B Lueza, J-Y Douillard, et al.
British Journal of Cancer|March 25, 2000
Extensive molecular screening for hereditary non-polyposis colorectal cancerB Dieumegard, S Grandjouan, J C Sabourin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2011
Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trialsT Reiman, R Lai, A S Veillard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2015
Phase I trial of everolimus in combination with thoracic radiotherapy in non-small-cell lung cancerE Deutsch, C Le Péchoux, L Faivre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2002
A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinomaM Ducreux, P Rougier, J-P Pignon, et al.
Pageof 13